Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Inc (NASDAQ: TLRY)'s meteoric rise immediately after its July 2018 IPO wowed analysts and investors alike.

Tilray Is Down 55% In 2019: What Do The Fundamentals Say?

Cannabis company Tilray, Inc. (NASDAQ: TLRY) participated in The Barclays Global Consumer Staples Conference, and CEO Brendan Kennedy told Bloomberg there is "a lot of interest" among participants in gaining new exposure to cannabis.

Tilray CEO Talks Global Cannabis Interest, New Participants In Bloomberg Interview

Aurora Cannabis

Canopy Growth

Cronos Group

HEXO Corp

Innovative Industrial Properties

Scotts Miracle-Gro

Each of these seven marijuana stocks can teach a valuable lesson into how to use technical analysis to identify important levels.

7 Marijuana Stocks With Critical Levels to Watch

After missing analyst estimates on profit loss, a new shipping agreement could be just what Tilray stock needs to soar high again. 
The post New Deals in Europe Could Boost Tilray Stock appeared first on InvestorPlace.

New Deals in Europe Could Boost Tilray Stock

Cowen analyst Vivien Azer slashed her price target for Tilray by 60%. So why did the pot stock jump on the news?

Why a Huge Price-Target Cut Was Actually Good News for This Beaten-Down Pot Stock

Aphria

These four Canadian cannabis producers benefit the most from international markets -- but in much different ways.

4 Canadian Cannabis Producers With the Highest International Sales

Conn's

Medicines

These stocks managed to overcome a big market downdraft.

Why Tilray, Conn's, and Medicines Company Jumped Today

Canadian cannabis company Tilray Inc. TLRY, +5.86% is poised to have its international operations become a key part of its growth story after a series of acquisitions that have created multiple entry points to the U.S.

Cannabis company Tilray's international business will soon be a key growth driver, analyst says

TLRY has had some positive developments, but I would not buy Tilray stock because of the large overhang it's facing.
The post Tilray Has Reported Good News, But I Would Not Buy TLRY Stock appeared first on InvestorPlace.

Tilray Has Reported Good News, But I Would Not Buy TLRY Stock

In yet another acquisition for big marijuana, Tilray nabs a small Canadian dispensary chain.

Tilray to Acquire Dispensary Operator FOUR20

Tilray agreed to buy Four20, which runs six recreational pot shops in Alberta. Tilray edged lower while most other marijuana stocks rose modestly.

Marijuana Stocks: Tilray Muted As Cannabis Producer Buys More Pot Shops

Tilray, Inc. (NASDAQ: TLRY) said Thursday it signed a definitive agreement to acquire all of the issued and outstanding securities of 420 Investments Ltd.

Tilray To Acquire Cannabis Retailer FOUR20

There are a ton of pot stocks out there, but only four of them have a realistic opportunity to strike gold in the long run.

The Only 4 Pot Stocks Worth Considering Long Term

Canadian cannabis company Tilray Inc. TLRY, +2.68% said Thursday it has agreed to acquire Four20, an adult-use cannabis retailer based in Calgary, Alberta in an all-stock deal.

Tilray to buy cannabis retailer Four20 for up to C$100 million in stock

CannTrust Holdings

They've taken a shellacking this year, but could these cannabis stocks now be bargains?

Are These 3 Beaten-Down Pot Stocks Bad News Buys?

Curaleaf Holdings, Inc.

GW Pharmaceuticals

Here's why marijuana stock market caps have gone up in smoke.

These 10 Pot Stocks Have Lost Nearly $21 Billion in Aggregate Value in 4 Months

Which stock wins in a one-on-one matchup between these two leading Canadian cannabis producers?

Better Buy: Canopy Growth vs. Tilray

These marijuana stocks have cultivation, export, or research deals with at least one dozen countries outside of Canada.

3 Pot Stocks With a Huge International Presence

Splunk

Retrophin

Find out how earnings and other factors hit these stocks.

Why Tilray, Splunk, and Retrophin Slumped Today

The company will deliver $3.3 million worth of medical cannabis from its facility in Portugal to Germany.

Tilray Signs Landmark European Shipment Deal

Hint: Most are years away from delivering consistent profits. But there's one notable exception.

When Will the Big Canadian Cannabis Producers Become Profitable?

Cara Therapeutics

OrganiGram Holdings Inc.

Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.
The post 10 Marijuana Stocks That Could See 100% Gains, If Not More appeared first on InvestorPlace.

10 Marijuana Stocks That Could See 100% Gains, If Not More

Tilray stock got a boost after the firm said its European invasion plans are to begin in Germany. Other marijuana stocks were mixed Wednesday.

This Marijuana Stock Moves To Begin Its European Invasion In Germany

Tilray, Inc. (NASDAQ: TLRY) said Wednesday it signed an agreement with Pharma GmbH (Cannamedical) through its subsidiary Tilray Portugal Unipessoal Lda.

Tilray Partners With Cannamedical To Export Medical Cannabis To Germany

Is a plunge of 85% or more really in store for one of the biggest Canadian cannabis producers?

News for Tilray Brands Stock (TLRY)